carcinoma

(redirected from Colorectal carcinoma)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.
Related to Colorectal carcinoma: Colorectal cancer

carcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

carcinoma

[‚kärs·ən′ō·mə]
(medicine)
A malignant epithelial tumor.

carcinoma

Pathol
1. any malignant tumour derived from epithelial tissue
2. another name for cancer
References in periodicals archive ?
Clinicopathological trends in colorectal carcinoma in a Black South African population.
The role of taxanes in treatment of colorectal carcinomas shall be proven in further clinical studies.
Loss of beterozygosity of chromosome 18q is common in primary colorectal carcinoma, but it is infrequent in small adenomas, leading to the conclusion that 18q LOH may contribute more to progression rather than initiation of colorectal carcinoma.
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma.
As indicated previously, there are distinct differences in the timing and frequency of genomic alterations observed in IBD-associated carcinogenesis and common sporadic colorectal carcinoma.
In the same study good safety, tolerability and encouraging first efficacy data for trabedersen was observed also in patients with advanced malignant melanoma or colorectal carcinoma.
I read with interest the excellent and informative review article by Kamel-Reidetal (1) on the "Validation of KRAS Testing for Anti-EGFR Therapeutic Decisions for Patients With Metastatic Colorectal Carcinoma.
We test only metastatic colorectal carcinoma since, overall, most colorectal carcinomas are surgically curable.
Objectives: To evaluate the safety and efficacy of the fermented mistletoe extract Iscador[TM] (ISC) in the supportive care of surgically treated patients with primary non-metastatic colorectal carcinoma in comparison with a parallel control group (control) without ISC from the same cohort.
Following its introduction into clinical practice over 40 years ago, 5-fluorouracil (5-FU) had been the standard chemotherapeutic agent for treating patients with advanced colorectal carcinoma.
Although several studies have shown the positive effects of checklists or templates on the completeness of histopathology reports on colorectal carcinoma resections, (14-23) just one has included more specific data on the sustainability of template use.
The effectiveness of Vectibix as a single agent for the treatment of EGFR-expressing, metastatic colorectal carcinoma is based on progression-free survival.